Hansard

I, too, thank Clare Adamson for bringing the debate to the chamber, and for all the work that she has done on pancreatic cancer over this session of Parliament.

I am glad that the Parliament is once again marking pancreatic cancer awareness month and highlighting the importance of greater awareness and timely diagnosis. I welcome the opportunity to contribute—I think that I have contributed in each of the previous annual debates.

It is important to take a moment to reflect on the scale of the illness and the profound impact that it has on many families. Others have mentioned the statistics, so I will not go back over them, but I will say that we must always remember that catching the cancer early dramatically improves the chances of treatment and recovery. We know from the statistics that eight in 10 people are diagnosed at a late stage, which means that they are often diagnosed too late for treatment. That is a tragedy. More than 50 per cent are diagnosed in emergency settings, such as accident and emergency, despite the vast majority of patients visiting their general practitioner multiple times before being diagnosed.

For patients, recognising the symptoms of pancreatic cancer represents a first step in diagnosis, especially in the absence of the early detection tests that others have mentioned. Symptoms can be vague, which can make the cancer really difficult to spot, so the public awareness campaigns that are run by charities and organisations to support early detection are crucial. I, too, thank the various organisations that do that work, and those that have contacted me ahead of today’s debate for their work and for all the helpful briefings. The briefings show the scale of the problem and the challenge ahead; they also show us what we have to work towards.

Other members have mentioned the importance of research and the related challenges and barriers, as well as the important tests that can detect the disease. We need all that work to come together so that we can improve survival rates. I noticed that, in the past 15 years, the five-year survival rate has increased from 3 per cent to 7 per cent. It has not moved at pace, but it shows that we can make a difference by working together, including with other nations.

Before closing, I will take a moment, as I often do, to reflect on health inequalities and their impact on outcomes for our constituents. We know that the detection of cancer in our more deprived communities can be very difficult. In those areas, people interact with health services in a very different way, and we have a responsibility to raise this issue time and again. The latest Public Health Scotland data revealed that the incidence of all cancers was 24 per cent greater in the most deprived areas compared with the least deprived areas. Often, that is about early detection and supporting people to get the right advice at the right time.

In previous debates, I have warned about the impact of health inequalities on some of our most vulnerable communities and called for urgent action in that regard. We must do more to empower our communities to speak to healthcare professionals when they need help, and to ensure that a clear and understandable plan is put in place to address any inequalities that people might face.

I thank the guests in the gallery for their attendance and all the members who have contributed to the debate.